Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Vitro Evaluation of Drug-Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor. | Pharmaceuticals (Basel) | 2024 | 38256953 | PubTator, text mining | PubMed |
| A Lactic Acid Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironmental Status in Patients with Hepatocellular Carcinoma. | Nutr Cancer | 2024 | 38226887 | PubTator, text mining | PubMed |
| Progress in the clinical effects and adverse reactions of ticagrelor. | Thromb J | 2024 | 38200557 | PubTator, text mining | PubMed |
| Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. | Int J Biol Sci | 2024 | 38164178 | PubTator, text mining | PubMed |
| Pharmacokinetic Interaction Between Imatinib and Metformin in Rats. | Eur J Drug Metab Pharmacokinet | 2024 | 38141154 | PubTator, text mining | PubMed |
| Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. | Clin Transl Sci | 2024 | 38140786 | PubTator, text mining | PubMed |
| Increasing the versatility of the biphenyl-fused-dioxacyclodecyne class of strained alkynes. | Org Biomol Chem | 2024 | 38131271 | PubTator, text mining | PubMed |
| Non-coding RNA and Drug resistance in cholangiocarcinoma. | Noncoding RNA Res | 2024 | 38125756 | PubTator, text mining | PubMed |
| No drug-drug interactions between selective prolyl-tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants. | Clin Transl Sci | 2024 | 38105420 | PubTator, text mining | PubMed |
| Organic cation transporters in psychiatric and substance use disorders. | Pharmacol Ther | 2024 | 38072333 | PubTator, text mining | PubMed |
| Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis. | Ther Drug Monit | 2024 | 38019456 | PubTator, text mining | PubMed |
| eRNAbase: a comprehensive database for decoding the regulatory eRNAs in human and mouse. | Nucleic Acids Res | 2024 | 37889077 | PubTator, text mining | PubMed |
| Promising use of metformin in treating neurological disorders: biomarker-guided therapies. | Neural Regen Res | 2024 | 37862207 | PubTator, text mining | PubMed |
| Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory site. | Arch Toxicol | 2024 | 37833491 | PubTator, text mining | PubMed |
| Bidirectional pharmacokinetic drug interactions between olaparib and metformin. | Cancer Chemother Pharmacol | 2024 | 37815561 | PubTator, text mining | PubMed |
| Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review. | Curr Diabetes Rev | 2024 | 37550919 | PubTator, text mining | PubMed |
| Interaction of systemic drugs causing ocular toxicity with organic cation transporter: an artificial intelligence prediction. | J Biomol Struct Dyn | 2024 | 37340665 | PubTator, text mining | PubMed |
| OCT1 regulates the migration of colorectal cancer cells by acting on LDHA. | Histol Histopathol | 2024 | 37014018 | PubTator, text mining | PubMed |
| Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes. | Res Pharm Sci | 2023 | 39005567 | PubTator, text mining | PubMed |
| Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines. | J Pharm Pharm Sci | 2023 | 38304488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=9